Delivery Order SPE2DR25D3401-SPE2DR26FL0UN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,174.22 to AmerisourceBergen Drug Corp for the supply of Methazolamide 50 mg tablets (100-count units). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and was finalized on July 29, 2025, with a completion deadline of July 30, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methazolamide 50 mg tablets (100-count units) with a contract value of $4,031.07. This competitively awarded, non-set-aside delivery order is classified as a firm fixed-price contract with an ultimate completion date of August 7, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,685.76 to AmerisourceBergen Drug Corp for the supply of Methazolamide 50 mg tablets (100 count) on October 22, 2025, with completion expected by October 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a $10,610.31 delivery order to AmerisourceBergen Drug Corp for the supply of Methazolamide Continuous Release Tablets 30mg, with an ultimate completion date of December 18, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order structure typical of pharmaceutical procurement under the DLA's medical supply framework. The award was made to AmerisourceBergen's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,122.66 to AmerisourceBergen Drug Corp for Methazolamide 50 mg tablets (100-count units) on June 2, 2025, with an ultimate completion date of June 3, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will be conducted at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 25, 2025, valued at $8,633.25 for the supply of Methazolamide Continuous Tablets 30mg to support the Defense Logistics Agency's Medical Supply Chain. The contract represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025 and performance location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and is issued as a child contract under...
- This federal contract award, valued at $1,496.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,802,739 units of Methazolamide 50 mg tablets in 100-count bottles, with a performance period ending on September 16, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- This federal contract award, valued at $1,122.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methazolamide 50 mg tablets, a pharmaceutical product, and is a Firm Fixed Price Delivery Order with a completion date of November 18, 2024. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award, valued at $7,493.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4565019016 - Methazolamide 50 mg tablets, a generic medication. The contract has a firm fixed price and an ultimate completion date of June 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $4,168.92, is for the supply of 4,564,361,959 units of the pharmaceutical product Methazolamide 50 mg Tablet. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical...
- SPE2DR25D3401Indefinite Delivery Contract
- SPE2DR25D3401-SPE2DR26FL0UNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,666.80 to AmerisourceBergen Drug Corp for the supply of Methazolamide 50 mg tablets in quantities of 100 units. The contract, which was competitively awarded without set-aside designation, was executed on December 22, 2025, with an ultimate completion date of December 23, 2025, and operates under firm fixed-price terms. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying an extensive range of medications, vaccines, and medical supplies to support military and veteran healthcare systems. The DLA's Medical Supply Chain relies on such contracts to distribute pharmaceutical products across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 12/21/25 |